Anar al contingut
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Tots els camps
Títol
Autor
Matèria
Signatura
ISBN/ISSN
Etiqueta
Trobar
Avançada
Paraoxonase polymorphism MET-L...
Citar
Enviar aquest missatge de text
Enviar per correu electrònic aquest
Imprimir
Exportar registre
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enllaç permanent
Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients
Dades bibliogràfiques
Autors principals:
Groves, C
,
Horton, V
,
Ritchie, A
,
Owen, R
,
Stratton, I
,
Green, F
,
Holman, R
,
Turner, R
Format:
Journal article
Publicat:
1998
Fons
Descripció
Ítems similars
Visualització del personal
Ítems similars
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
per: Stevens, R, et al.
Publicat: (2004)
Silent myocardial infarction is an independent risk factor for fatal myocardial infarction in patients with Type 2 diabetes
per: Cull, C, et al.
Publicat: (2007)
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations
per: Ilia Leviev, et al.
Publicat: (2001-04-01)
Serum myeloperoxidase, paraoxonase, and plasma asprosin concentrations in patients with acute myocardial infarction
per: Handan Ciftci, et al.
Publicat: (2024-04-01)
UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
per: Keavney, B, et al.
Publicat: (1995)